Last update 01 Nov 2024

SLITRK6 x Tubulin

Basic Info

Related Targets
SLITRK6Tubulin

Related

1
Drugs associated with SLITRK6 x Tubulin
Sirtratumab Vedotin
Target
SLITRK6 x Tubulin
Mechanism
SLITRK6 inhibitors [+1]
Active Org.
Agensys, Inc.Agensys, Inc. [+1]
Originator Org.
Agensys, Inc.Agensys, Inc.
Active Indication
Bladder Cancer
Inactive Indication
Metastatic urothelial carcinoma
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with SLITRK6 x Tubulin
NCT01963052 / CompletedPhase 1
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer
100 Clinical Results associated with SLITRK6 x Tubulin
Login to view more data
100 Translational Medicine associated with SLITRK6 x Tubulin
Login to view more data
0 Patents (Medical) associated with SLITRK6 x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free